ArticleOncoTargets and therapy2017

Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer.

Jin Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.